Skip to main content
. 2021 Jul 28;9(2):329–346. doi: 10.1007/s40487-021-00161-5

Fig. 1.

Fig. 1

Overall survival in A the National Lymphocare Study and B the independent validation cohort: comparison of FL patients with POD24 (“early POD”) versus patients without POD24 (“reference”) [18]. Reproduced with permission. Copyright © 2015, Wolters Kluwer Health. POD progression of disease